ICICI Lombard General Insurance Company (ICICI
Lombard GIC) has launched a product called ICICI Lombard Complete
Health Insurance, which offers critical illness cover and
hospitalisation coverage.
The critical illness aspect of the product
covers procedures including cancer, a major organ transplant and
end stage liver failure.
Hospitalisation cover includes nursing
expenses, intensive care unit charges and doctor or surgeons’
fees.
Bhargav Dasgupta, ICICI Lombard GIC’s managing
director and CEO was reported in the Economic Times as saying that
the Complete Health Insurance product is the final outcome of
detailed market research undertaken,
The complete health care insurance scheme will
reportedly be available for a tenure of 1 or 2 years, for
individual and family floater plans.
ICICI Lombard GIC is a joint venture between
India’s ICICI Bank and Canada’s Fairfax Financial
Holdings.
The insurer recorded a gross written premium
of INR 53.6bn $963m for the year ended March 31, 2012.